INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Vistagen Therapeutics, Inc. (VTGN) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
VistaGen Therapeutics(US:VTGN) Globenewswire·2026-01-17 00:04ATLANTA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Vistagen Therapeutics, Inc. (“Vistagen” or the “Company”) (NASDAQ: VTGN). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts regarding the risks of failure associated with Vistagen’s Phase 3 PALISADE-3 trial study of fasedienol. If you purchased Vistagen shares between April 1, 2024 and December 16, 2025, and experienced a significant l ...